Abstract
The immune system’s function is to protect us against invading pathogens such as viruses, bacteria, parasites, and even the runaway growth of cancer cells. T lymphocytes play a major role in these immune responses, and in most cases the outcome is beneficial, such as killing infected cells or helping B-cells produce antibodies. In many cases, medical science has been capable of augmenting or enhancing the beneficial immune responses. Successes are numerous. Vaccines are now available against viral diseases such as influenza, hepatitis, and polio, and against bacterial infections such as diptheria, whooping cough, and tetanus. Clearly, however, much more progress is required in developing vaccines efficacious against diseases such as cancer and AIDS.
Keywords
- Experimental Autoimmune Encephalomyelitis
- Myelin Basic Protein
- Major Histocompatibility Complex Type
- Affinity Threshold
- Inhibit Antigen Presentation
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
A. Sette and H.M. Grey, Chemistry of peptide interactions with MHC proteins, Curr. Opin. Immunol.4:79 (1992).
D.L. Mueller, M.K. Jenkins, and R.H. Schwartz, Clonal expansion versus functional clonal inactivation:A costimulatory signalling pathway determines the outcome of T-cell antigen receptor occupancy, Ann. Rev. Immunol.7:445 (1989).
L. Adorini, J-C. Guéry, G. Rodriguez-Tarduchy, and S. Trembleau, Selective immunosuppression, Immunol. TodayJ4:285 (1993).
A. Lanzavecchia, Identifying strategies for immune intervention. Science260:937 (1993).
M.T. De Magistris, J. Alexander, M. Coggeshall, A Altman, RCA. Gaeta, H.M. Grey, and A. Sette, Antigen analog-major histocompatibility complexes act as antagonists of the T-cell receptor, Cell68:625 (1992).
M.T. De Magistris, J. Alexander, M. Coggeshall, A Altman, RCA. Gaeta, H.M. Grey, and A. Sette, Antigen analog-major histocompatibility complexes act as antagonists of the T-cell receptor, Cell68:625 (1992).
S.C. Jameson, ER. Carbone, and MJ. Bevan, Clone-specific T-cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T-cells, J. Exp. Med.177:1541 (1993).
J. Alexander, K. Snoke, J. Ruppert, J. Sidney, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, RCA. Gaeta, S.M. Colón, H.M. Grey, and A. Sette, Functional consequences of engagement of the T-cell receptor by low affinity ligands, J. Immunol.150:1 (1993).
B.D. Evavold and P.M. Allen, Separation of IL-4 production from Th-cell proliferation by an altered T-cell receptor ligand, Science252:1308 (1991).
B.D. Evavold, J. Sloan-Lancaster, B.L. Hsu, and P.M. Allen, Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides, J. Immunol.150:3131 (1993).
T. Tenakin, Agonist, partial agonists, antagonists, inverse agonists and agonist/ antagonists? Trends Pharmacol. Sci.8:423 (1987).
J. Ruppert, J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H.M. Grey, and A. Sette, Effect of T-cell receptor antagonism on interaction between T-cells and antigen-presenting cells and on T-cell signaling events, Proc. Natl. Acad. Sci. USA90:2675 (1993).
J. Ruppert, J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H.M. Grey, and A. Sette, Effect of T-cell receptor antagonism on interaction between T-cells and antigen-presenting cells and on T-cell signaling events, Proc. Natl. Acad. Sci. USA90:2675 (1993).
J.H. Brown, T.S. Jardetzky, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley, Three-dimensional structure of the human class II histompatibility antigen HLA-DR1, Nature364:33 (1993).
A.G. Lamont, A. Sette, R. Fujinami, S.M. Colón, C. Miles, and H.M. Grey, Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAS molecules, J. Immunol.145:1687 (1990).
D.C Wraith, D.E. Smilek, D.J. Mitchell, L. Steinman, and H.O. McDevitt, Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy, Cell59:247 (1989).
D.E. Smilek, D.C. Wraith, S. Hodgkinson, S. Dwivedy, L. Steinman, and H.O. McDevitt, A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis, Proc. Natl Acad. Sci. USA88:9633 (1991).
K. Snoke, J. Alexander, A. Franco, L. Smith, J.V. Brawley, P.O. Concannon, H.M. Grey, A. Sette, and P. Wentworth, The inhibition of different T-cell lines specific for the same antigen with TCR antagonist peptides, J. Immunol.151:1 (1993).
J. Sprent, D. Lo, E.-K. Gao, and Y. Ron, T-cell selection in the thymus, Immunol. Rev.101:173 (1988).
P. Kisielow, H.S. Teh, H. Bluthmann, and H. von Boehmer, Positive selection of antigen-specific T-cells in thymus by restricting MHC molecules. Nature335:730 (1988).
H. Pircher, U.H. Rohrer, D. Moskophidis, R.M. Zinkernagel, and H. Hengartner, Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature351:482 (1991). 117
N.J. Vasquez, J. Kaye, and S.M. Hedrick, In vivo and in vitro clonal deletion of double-positive thymocytes, J. Exp. Med. 175:1307 (1992).
J. Sloan-Lancaster, B.D. Evavold, and P.M. Allen, Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells, Nature363:156 (1993).
D.F. Hunt, H. Michel, T.A. Dickinson, J. Shabanowitz, A.L. Cox, K. Sakaguchi, E. Appella, H.M. Grey, and A. Sette, Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad, Science256. 1817 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Plenum Press, New York
About this chapter
Cite this chapter
Alexander, J. et al. (1995). Antigen analogs as therapeutic agents. In: Aledort, L.M., Hoyer, L.W., Lusher, J.M., Reisner, H.M., White, G.C. (eds) Inhibitors to Coagulation Factors. Advances in Experimental Medicine and Biology, vol 386. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0331-2_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0331-2_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8001-6
Online ISBN: 978-1-4613-0331-2
eBook Packages: Springer Book Archive